Basal cell carcinoma (BCC) of the eyelid is a relatively uncommon facial tumor. The goals for treatment are both definitive tumor control and preservation of the functional structures. The roles of radiotherapy and surgery in this regard are controversial. We report a 77-year-old male with a BCC of the eyelid treated by 6 MeV electron beam therapy alone to a total of 5940 cGy in 33 fractions, with an eye shield. The tumor responded well. There was no recurrence or serious ocular complication in 24 months of follow up. With careful patient selection, radiotherapy is a safe, simple alternative to surgery for BCC of the eyelid, yielding good local control and cosmetic results.